Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS · Delayed Price · Currency is USD
0.790
-0.110 (-12.22%)
At close: Dec 5, 2025

Clearside Biomedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
4727367164132
Upgrade
Market Cap Growth
-94.71%-1.32%8.31%-58.91%23.85%11.02%
Upgrade
Enterprise Value
59988646140120
Upgrade
Last Close Price
0.7914.2517.5516.8041.2541.10
Upgrade
PE Ratio
----436.39-
Upgrade
PS Ratio
1.2443.308.8850.805.5516.78
Upgrade
PB Ratio
-0.08-1.85-4.596.364.3215.12
Upgrade
P/TBV Ratio
---6.364.3215.12
Upgrade
EV/Sales Ratio
17.7159.1610.4634.954.7215.16
Upgrade
Debt / Equity Ratio
-1.14-1.35-2.703.320.020.23
Upgrade
Asset Turnover
0.160.060.190.030.950.34
Upgrade
Quick Ratio
2.554.284.318.358.721.74
Upgrade
Current Ratio
2.984.444.428.549.081.82
Upgrade
Return on Equity (ROE)
----135.63%1.61%-182.83%
Upgrade
Return on Assets (ROA)
-70.35%-61.04%-36.40%-40.17%-1.26%-48.63%
Upgrade
Return on Capital (ROIC)
-125.63%-88.70%-42.56%-44.78%-1.59%-79.19%
Upgrade
Return on Capital Employed (ROCE)
-258.80%-142.10%-91.30%-66.50%-1.60%-191.20%
Upgrade
Earnings Yield
-628.71%-47.68%-44.49%-48.87%0.23%-13.74%
Upgrade
FCF Yield
-525.92%-35.63%-27.27%-20.19%-6.54%-9.94%
Upgrade
Buyback Yield / Dilution
-9.72%-19.41%-2.66%-0.50%-28.81%-21.84%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.